Clinical Trials

    Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (CREST)

    Investigator: Raj Satkunasivam

    Study Coordinator: Taliah Muhammad

    Status: Open Not Enrolling

    ClinicalTrials.gov Number: NCT04165317

    Phone: 346.238.4523

    Protocol Number: PRO00024845

    Description


    Primary Purpose: Treatment